Contamination bias in the estimation of child maltreatment causal effects on adolescent internalizing and externalizing behavior problems

JM Felt, U Chimed‐Ochir, KA Shores… - Journal of child …, 2024 - Wiley Online Library
Background When unaddressed, contamination in child maltreatment research, in which
some proportion of children recruited for a nonmaltreated comparison group are exposed to …

Mortality reduction and cumulative excess incidence (CEI) in the prostate-specific antigen (PSA) screening era

PW McLaughlin, MM Cousins, A Tsodikov, PD Soni… - Scientific Reports, 2024 - nature.com
The extent to which PSA screening is related to prostate cancer mortality reduction in the
United States (US) is controversial. US Surveillance, Epidemiology, and End Results …

Prostate-Specific Antigen Screening and Prostate Cancer Mortality: An Emulation of Target Trials in US Medicare

X García-Albéniz, J Hsu, R Etzioni, JM Chan… - JCO Clinical Cancer …, 2024 - ascopubs.org
PURPOSE No consensus about the effectiveness of prostate-specific antigen (PSA)
screening exists among clinical guidelines, especially for the elderly. Randomized trials of …

Translational Research: Bridging the Gap Between Bench and Bedside

R Marima, E Sambo, A Basera, L Gabada… - … Prostate Cancer Care …, 2024 - Springer
Prostate cancer (PC) is a health crisis worldwide. A notable number of all men who develop
prostate PC progress to castration-resistant metastatic disease. Androgen deprivation …

[PDF][PDF] Use of TP4303 to identify prostate cancer cells in voided urine samples

SC Ghagane, S Rangrez, RB Nerli… - The Canadian Journal …, 2024 - canjurol.com
Introduction: Prostate cancer is the second most common malignancy in men worldwide.
Genomic VPAC receptors are expressed on malignant prostate cancer cells and can be …

[引用][C] Effect of an Invitation or the Effect of Participation: What Should Randomized Controlled Trials of Cancer Screening Examine?

PD Sasieni - Journal of Clinical Oncology, 2024 - ascopubs.org
Earlier detection of cancer offers an opportunity to save lives from the disease, but there are
challenges in realizing its potential. 1 Not least is how best to evaluate new screening …